These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 35583251

  • 1. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
    González J, Jatem E, Roig J, Valtierra N, Ostos E, Abó A, Santacana M, García A, Segarra A.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2102-2110. PubMed ID: 35583251
    [Abstract] [Full Text] [Related]

  • 2. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Kim WJ, Jeon YK, Kim BH, Kwak IS, Lee EK, Kim YK.
    Diabetes Metab Res Rev; 2014 Nov 19; 30(8):736-41. PubMed ID: 24687388
    [Abstract] [Full Text] [Related]

  • 3. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE.
    J Diabetes Complications; 2017 Dec 19; 31(12):1704-1709. PubMed ID: 29037450
    [Abstract] [Full Text] [Related]

  • 4. Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Knowler WC, Rovin BH, Wu H, Klein JB, Mifflin TE, Feldman HI, Vasan RS, Kimmel PL, Kusek JW, Mauer M, CKD Biomarkers Consortium and the RASS Investigators.
    Nephrol Dial Transplant; 2015 Apr 19; 30(4):599-606. PubMed ID: 25648911
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
    Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, Rossing P.
    Kidney Int; 2011 May 19; 79(10):1113-8. PubMed ID: 21270761
    [Abstract] [Full Text] [Related]

  • 8. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 May 19; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov 19; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    Ren Fail; 2003 May 19; 25(3):439-44. PubMed ID: 12803507
    [Abstract] [Full Text] [Related]

  • 13. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L, Beck C, Rutz S, Manuilova E, Domke I, Guder WG, Hofmann W.
    Clin Chem Lab Med; 2014 Apr 19; 52(4):537-46. PubMed ID: 24243749
    [Abstract] [Full Text] [Related]

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM, Mauer M, International Diabetic Nephropathy Study Group.
    Pediatr Endocrinol Rev; 2008 Aug 19; 5 Suppl 4():958-63. PubMed ID: 18806710
    [Abstract] [Full Text] [Related]

  • 15. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK.
    Diabetes Res Clin Pract; 2012 Aug 19; 97(2):251-7. PubMed ID: 22440044
    [Abstract] [Full Text] [Related]

  • 16. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
    Bjornstad P, Singh SK, Snell-Bergeon JK, Lovshin JA, Lytvyn Y, Lovblom LE, Rewers MJ, Boulet G, Lai V, Tse J, Cham L, Orszag A, Weisman A, Keenan HA, Brent MH, Paul N, Bril V, Perkins BA, Cherney DZI.
    Diabetes Obes Metab; 2019 Mar 19; 21(3):575-583. PubMed ID: 30311395
    [Abstract] [Full Text] [Related]

  • 17. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L, Li XQ, Chang DY, Zhang H, Li JJ, Wu SL, Zhang LX, Chen M, Zhao MH.
    Nephrol Dial Transplant; 2020 Feb 01; 35(2):291-297. PubMed ID: 30357416
    [Abstract] [Full Text] [Related]

  • 18. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study.
    Nielsen SE, Hansen HP, Jensen BR, Parving HH, Rossing P.
    Nephron Clin Pract; 2011 Feb 01; 118(2):c130-5. PubMed ID: 21160226
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy.
    Su Z, Widomski D, Ma J, Namovic M, Nikkel A, Leys L, Olson L, Salte K, Donnelly-Roberts D, Esbenshade T, McGaraughty S.
    Am J Nephrol; 2016 Feb 01; 44(5):339-353. PubMed ID: 27736813
    [Abstract] [Full Text] [Related]

  • 20. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.
    Wang W, You Z, Steele CN, Gitomer B, Chonchol M, Nowak KL.
    BMC Nephrol; 2024 Jun 25; 25(1):206. PubMed ID: 38918734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.